There’s new hope for Australians living with a severe flesh eating ulcer, with expanded subsidised access to a key medicine on the Pharmaceutical Benefits Scheme (PBS). From 1 December, access to Rimycin 150® and 300® (rifampicin) will be expanded on the PBS for the treatment of Buruli ulcer (Mycobacterium ulcerans infection). It is expected 425…
Thousands of Australians with debilitating back and joint pain will have access to a life changing treatment option through the Pharmaceutical Benefits Scheme (PBS) which would otherwise cost tens of thousands of dollars. From December 1, access to Taltz® (ixekizumab) on the PBS will be expanded for patients with active ankylosing spondylitis. Without the PBS…
Patients living with one of Australia’s most common forms of leukaemia are set to benefit from expanded access to a breakthrough medicine through the Pharmaceutical Benefits Scheme (PBS). From 1 December, access to Venclexta® (venetoclax) will be extended in combination with obinutuzumab for the first-line treatment of patients with chronic lymphocytic leukaemia who have co-existing…
The Morrison Government is supporting six new COVID-19 research projects across four institutions, allowing researchers continue to examine the virus and our response to the pandemic. More than $4 million will be distributed from the Medical Research Future Fund (MRFF) through two grant rounds to institutions including Monash University, Deakin University and Macquarie University. These…
E&OE… Topics: Extension of telehealth; $4 million for COVID digital health delivery; European COVID cases numbers; AstraZeneca vaccine; Quarantine facilities; State borders; WA state border; Travel bubble with New Zealand; Returning Australian travellers. GREG HUNT: To have somebody who’s an outstanding medical professional in his own right as well as an outstanding medical leader, I…
E&OE… Topics: Acknowledgement of ResMed; Vaccines for COVID-19; Oxford/AstraZeneca Vaccine; Qantas; Vaccine rollout; NSW Premier; GREG HUNT: Thanks to everybody joining us here today, in particular to Brett Sandercock, the CFO of ResMed, and to Alex Hawke, who’s not only the local member, but he’s been responsible for our overseas program as Minister,…
An innovative nasal treatment to fight COVID-19, common colds and flu is being taken to the next stage of testing, thanks to the Morrison Government’s $500 million Biomedical Translation Fund. Developed by Australian biotech company Ena Respiratory, INNA-051 works by stimulating the innate immune system, the first line of defence against the invasion of…
Work has begun to construct a $7 million palliative care facility for terminally ill people in Hervey Bay. The new purpose-built Fraser Coast Hospice will provide 24-hour home-like accommodation, professional and compassionate care to clients at the end of their life, and bereavement care to their families. Federal Member for Hinkler and Minister…
E&OE… Topics: COVID-19 Vaccines; South Australia COVID-19 outbreak; Border closures. LEON BYNER: Greg Hunt, thanks for joining us this morning. As you know, South Australia went into lockdown at midnight last night; 23 cases, what do you think? Good thing? GREG HUNT: Look, obviously, we recognise the situation in South Australia. …
The Australian Government is taking strong steps to address the risk of antimicrobial resistance (AMR) as part of World Antimicrobial Awareness Week. AMR is a significant global health threat and is the result of viruses and bacteria changing over time, which can lead to them no longer responding to medicines and medical treatment. …